Stock Track | Alvotech Plummets 5.11% Intraday Following Analyst Price Target Cuts

Stock Track03-24

Alvotech's stock plummeted 5.11% during Tuesday's intraday trading session, reflecting significant selling pressure on the biopharmaceutical company.

The sharp decline appears to be driven by negative analyst actions, with both Deutsche Bank and Barclays significantly reducing their price targets for Alvotech. Deutsche Bank lowered its target to $4 from $8 while maintaining a Hold rating, representing a 50% reduction. Similarly, Barclays cut its target to $4 from $5 and maintained an Underweight rating on the shares.

These substantial downward revisions by major financial institutions likely contributed to investor concerns about Alvotech's valuation and future prospects, prompting the sell-off during the trading day.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188083331?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 21:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188083331","market":"nz","top_or_hot":-1,"title":"Stock Track | Alvotech Plummets 5.11% Intraday Following Analyst Price Target Cuts","media":"Stock Track","content":"<p>Alvotech's stock plummeted 5.11% during Tuesday's intraday trading session, reflecting significant selling pressure on the biopharmaceutical company.</p><p>The sharp decline appears to be driven by negative analyst actions, with both Deutsche Bank and Barclays significantly reducing their price targets for Alvotech. Deutsche Bank lowered its target to $4 from $8 while maintaining a Hold rating, representing a 50% reduction. Similarly, Barclays cut its target to $4 from $5 and maintained an Underweight rating on the shares.</p><p>These substantial downward revisions by major financial institutions likely contributed to investor concerns about Alvotech's valuation and future prospects, prompting the sell-off during the trading day.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alvotech Plummets 5.11% Intraday Following Analyst Price Target Cuts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alvotech Plummets 5.11% Intraday Following Analyst Price Target Cuts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-24 21:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alvotech's stock plummeted 5.11% during Tuesday's intraday trading session, reflecting significant selling pressure on the biopharmaceutical company.</p><p>The sharp decline appears to be driven by negative analyst actions, with both Deutsche Bank and Barclays significantly reducing their price targets for Alvotech. Deutsche Bank lowered its target to $4 from $8 while maintaining a Hold rating, representing a 50% reduction. Similarly, Barclays cut its target to $4 from $5 and maintained an Underweight rating on the shares.</p><p>These substantial downward revisions by major financial institutions likely contributed to investor concerns about Alvotech's valuation and future prospects, prompting the sell-off during the trading day.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALVO","symbol_name":"Alvotech","start_time":0,"source_url":"","article_id":"1188083331","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188083331","pubTimestamp":1774360237,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alvotech's stock plummeted 5.11% during Tuesday's intraday trading session, reflecting significant selling pressure on the biopharmaceutical company.The sharp decline appears to be driven by negative...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALVO":"Alvotech"},"translate_title":"个股追踪|分析师下调目标价后Alvotech盘中暴跌5.11%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALVO":1},"content_text":"Alvotech's stock plummeted 5.11% during Tuesday's intraday trading session, reflecting significant selling pressure on the biopharmaceutical company.The sharp decline appears to be driven by negative analyst actions, with both Deutsche Bank and Barclays significantly reducing their price targets for Alvotech. Deutsche Bank lowered its target to $4 from $8 while maintaining a Hold rating, representing a 50% reduction. Similarly, Barclays cut its target to $4 from $5 and maintained an Underweight rating on the shares.These substantial downward revisions by major financial institutions likely contributed to investor concerns about Alvotech's valuation and future prospects, prompting the sell-off during the trading day.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188083331","isCrawlerRequest":true}